Day: August 26, 2024

Daré Bioscience Announces Publication in The Journal of Sexual Medicine of Positive Safety Findings from the Phase 2b RESPOND Clinical Study of Sildenafil Cream, 3.6%

Published data show that topical Sildenafil Cream, 3.6% was safe and well tolerated by women and their partners across 1,357...

error: Content is protected !!